Neurotoxin Administration
Neurotoxin Administration - Related Videos
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
0 Views •
Cited by 5 •
2014
The BoTest Matrix botulinum neurotoxin (BoNT) detection assays rapidly purify and quantify BoNT from a range of sample matrices. Here, we present a protocol for the detection and quantification of BoNT from both solid and liquid matrices and demonstrate the assay with BOTOX, tomatoes, and milk.
15:05
Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
0 Views •
Cited by 9 •
2015
A custom protocol is described to differentiate mouse ES cells into defined populations of highly pure neurons exhibiting functioning synapses and emergent network behavior. Electrophysiological analysis demonstrates the loss of synaptic transmission following exposure to botulinum neurotoxin serotypes /A-/G and tetanus neurotoxin.
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
0 Views •
Cited by 4 •
2013
The botulinum neurotoxin type A light chain (BoNT/A LC) is a metalloprotease that enters motor neurons, cleaves its substrate SNAP-25, and disrupts neurotransmission, thereby resulting in flaccid paralysis. Utilizing a high-throughput-compatible FRET-based assay, large libraries of small molecules can be screened for their impact on BoNT/A LC enzymatic activity.
09:29
Self-administration Studies
0 Views •
2023
Behavioral reinforcement induced by the rewarding feelings following substance use sometimes leads to addiction, which is demonstrated by increased self-administration. Drug self-administration studies in rodents model human behavior during drug abuse. These models are useful in understanding the neurobiological behavior of addiction in order to help scientists discover new treatments for drug dependence. This video reviews the concepts underlying self-administration studies. A general...
09:38
Compound Administration II
0 Views •
2016
Source: Kay Stewart, RVT, RLATG, CMAR; Valerie A. Schroeder, RVT, RLATG. University of Notre Dame, IN Compound administration is often an integral component of an animal study. Many factors need to be evaluated to ensure that the compound is delivered correctly. The route of administration affects the mechanisms of absorption. The characteristics of the substance to be introduced (the pH, viscosity, and concentration) may dictate which route of administration is selected.
FAQs
Their effects depend on which neuronal process they interfere with. Some compounds alter neurotransmitter release, changing communication between neurons, whereas others affect ion-channel activity and therefore the electrical behavior of cells. Neurotoxins may also compromise neuronal survival. Distinguishing these outcomes helps investigators determine whether a circuit deficit reflects altered signaling, impaired excitability, or loss of neurons.
These variables determine which tissue experiences the compound, how much exposure occurs, and when the neural effect develops. Precise placement can restrict disruption to a defined brain region or cell population, while controlled dosing and timing help limit unintended effects. Consistency across all three factors improves reproducibility and makes comparisons between experimental groups more interpretable.
A toxin that changes neurotransmitter release can expose how communication depends on a circuit, while one that alters ion-channel activity can reveal the importance of neuronal electrical behavior. Effects on neuronal survival provide different information by showing which cells are vulnerable when they are damaged or lost. Comparing these outcomes helps separate functional circuit roles from cellular susceptibility.
Planning begins by identifying the brain region or cell population to study and selecting an appropriate delivery route. Researchers then define the dose and exposure timing, position the administration site carefully, and limit spread to unintended tissue. The resulting neural changes are interpreted in relation to the targeted location and exposure conditions, supporting more reproducible circuit or injury models.
Researchers apply this approach to map circuit function, investigate how specific neural populations contribute to behavior or signaling, and examine mechanisms of neuronal vulnerability. It can also produce models of neurodegeneration or neural injury. These applications allow investigators to connect controlled disruption of nervous system tissue with changes relevant to disease processes and neural function.
Once controlled neural damage or dysfunction has been produced, researchers can examine whether an intervention preserves neuronal function, limits cell vulnerability, or supports recovery. The model therefore links a defined neural insult with treatment outcomes. Careful control of administration site, dose, and timing is important because inconsistent exposure can obscure whether observed effects arise from the treatment or from variation in the injury.